ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025

(NASDAQ:ICCC), PORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended June 30, […]

American Oncology Network and The Center for Cancer and Blood Disorders Welcome Dr. Garrett Diltz and Dr. Shreya Desai

(Other OTC:AONC),(OTC US:AONC), BETHESDA, Md., Aug. 07, 2025 (GLOBE NEWSWIRE) — American Oncology Network (AON), one of the nation's fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), are pleased to welcome Board-certified medical oncologists Garrett Diltz, MD, and Shreya Desai, MD, to the care team.

Rocket Doctor Strengthens Access to Care Across Ontario as ER Closures and Physician Shortages Rise

(CNSX:TRUE.CN),(OTC US:TREIF),(OTCQB:TREIF),(Boerse Frankfurt – Freiverkehr:939), 2024 marked the worst year on record for ER closures in Ontario, with 1 in 5 hospitals experiencing unplanned shutdowns, especially in rural areas. Ontario's family physician workforce is aging, with 15% of patients attached to doctors nearing retirement and 2.5 million Ontarians lacking a family doctor as of 2023.

CTSI CEO Salvador Galván Wins Two Business Worldwide Magazine 2025 CEO Awards

Salvador Galván, CEO of Canarias Tecnológica y Sistemas de Información (CTSI), has been named twice in the 2025 Business Worldwide Magazine CEO Awards, winning two prestigious titles: “Most Innovative CEO in Public Sector Digital Transformation – Spain” and “Visionary CEO in Public Sector Technology & Innovation.” Business Worldwide Magazines CEO Awards celebrate outstanding individuals who

Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments

(NasdaqGM:BRNS), The final cohort of the single ascending dose (SAD) part of the Phase 1 AVALON trial initiated, with the SAD data readout expected early in the fourth quarter of 2025; The multiple ascending dose (MAD) part of the AVALON trial initiated; Available resources and cash runway guidance into 2027 remains unchanged. GERMANTOWN, Md., Aug.

Tether Acquires Minority Stake in Bit2Me and Leads €30 Million Investment Round

— Tether Ventures, the independent investment arm of Tether, the largest company in the digital asset industry and issuer of the world's most capitalized stablecoin -USDT-has acquired a minority stake in Bit2Me and is leading a €30 million investment round. — Bit2Me has become the first Spanish-speakingfintech to receive authorization from Spain's CNMV to operate

Leatt Corp Announces Results for the Second Quarter 2025

Global revenues increase 61%; Net income increases 208% Leatt Corporation (OTCQB: LEAT), a leading developer and marketer of head-to-toe protective equipment for MOTO, MTB, and a wide range of extreme and high-velocity sports, today announced financial results for the second quarter ending June 30, 2025. All financial numbers are in U.S. dollars. Second Quarter 2025

Tidewave Bio Reaches Key Regulatory Milestone with FDA INTERACT Meeting Scheduled for August 2025

LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — Tidewave Bio, a biotechnology company developing a novel immune activation platform for solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has accepted its request for an INTERACT meeting, scheduled for August 2025. This regulatory milestone marks a critical step in Tidewave's effort to

REMINDER: Lassonde Industries Inc. Will Hold a Conference Call to Discuss Its Second Quarter 2025 Financial Results

(TSX:LAS-A.TO),(TSX:LAS.A), ROUGEMONT, Quebec, Aug. 07, 2025 (GLOBE NEWSWIRE) — Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) is pleased to announce that it will host a conference call to discuss its financial results for the second quarter of 2025 on Friday, August 8, 2025. Mr. Vince Timpano, Chief Executive Officer, and Mr. Eric Gemme,

SYNERGEN Health and Compass Surgical Partners Announce Strategic Collaboration to Transform Financial Operations for High-Performing Ambulatory Surgery Centers

Collaboration brings together ASC management expertise and tech-enabled revenue cycle services to help ASCs scale with confidence SYNERGEN Health, a leading provider of technology-enabled revenue cycle management (RCM) services and solutions, today announced a strategic collaboration with Compass Surgical Partners, a premier development and management partner of independent ambulatory surgery centers (ASCs). https://mma.prnewswire.com/media/2745852/SYNERGEN_Health_Logo.jpg Through this

Scroll to Top